Macrophage Cell Membrane‐Cloaked Nanoplatforms for Biomedical Applications

Abstract

Biomimetic approaches utilize natural cell membrane-derived nanovesicles to camouflage nanoparticles to circumvent some limitations of nanoscale materials. This emergent cell membrane-coating technology is inspired by naturally occurring intercellular interactions, to efficiently guide nanostructures to the desired locations, thereby increasing both therapeutic efficacy and safety. In addition, the intrinsic biocompatibility of cell membranes allows the crossing of biological barriers and avoids elimination by the immune system. This results in enhanced blood circulation time and lower toxicity in vivo. Macrophages are the major phagocytic cells of the innate immune system. They are equipped with a complex repertoire of surface receptors, enabling them to respond to biological signals, and to exhibit a natural tropism to inflammatory sites and tumorous tissues. Macrophage cell membranefunctionalized nanosystems are designed to combine the advantages of both macrophages and nanomaterials, improving the ability of those nanosystems to reach target sites. Recent studies have demonstrated the potential of these biomimetic nanosystems for targeted delivery of drugs and imaging agents to tumors, inflammatory, and infected sites. The present review covers the preparation and biomedical applications of macrophage cell membranecoated nanosystems. Challenges and future perspectives in the development of these membrane-coated nanosystems are addressed.

Pro-efferocytic macrophage membrane biomimetic nanoparticles for the synergistic treatment of atherosclerosis via competition effect

“…This suggests that macrophage membrane coating strategy can significantly enhance the targeting and accumulation rate of nanoparticles to the atherosclerotic plaque area. Indeed, the immune evasion ability exhibited by macrophages is essentially a consequence of their surface membrane proteins [ 38 ]. Macrophages can identify MM@Lips-SHP1i NPs as “self-particles” due to the “self-marker” CD47 expressed on the macrophage membrane.…”

Technological challenges of biomembrane-coated top-down cancer nanotherapy

“…Nucleusfree cells are substantially easier to isolate and purify, which favours RBC and platelet usage. Extrusion and sonication are common coating methods in laboratory settings with moderate scalability 8 . The former method suffers from high material loss, whereas sonication leads to polydisperse coating, which can translate into unpredictable PK and PD.…”

Cell membrane biomimetic nanomedicines for cancer phototherapy

“…Due to the complexity of the blood‐brain barrier (BBB), which hinders the delivery of PD‐1 antibodies to tumor sites and further reduces the efficacy. It has been reported that macrophages can cross the BBB and target tumor tissue 91 . PD‐1‐MM@PLGA/RAPAs could not only reduce damage to the central nervous system across the BBB, but also combine ICB and CT to obtain the greatest antiglial in vivo compared to other groups.…”